A Study of SGN-B7H4V in Advanced Solid Tumors

A Study of SGN-B7H4V in Advanced Solid Tumors
Conditions:   Ovarian Neoplasms;   Peritoneal Neoplasms;   Fallopian Tube Neoplasms;   Triple Negative Breast Neoplasms;   HER2 Negative Breast Neoplasms;   Hormone Receptor Positive Breast Neoplasms;   Endometrial Neoplasms;   Carcinoma, Non-Small-Cell Lung;   Cholangiocarcinoma;   Gallbladder Carcinoma
Intervention:   Drug: SGN-B7H4V
Sponsor:   Seagen Inc.

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

July 27, 2022Comments OffClinicalTrials.gov | Endocrinology Clinical Trials | Endocrinology Studies | US National Library of Medicine